Feasibility Pilot Clinical Trial of Omega-3 Supplement vs. Placebo for Post Covid-19 Recovery Among Health Care Workers
Feasibility Pilot Clinical Trial of Omega-3 (EPA+DHA) Supplement vs. Placebo for Post-Acute Sequelae of Coronavirus-19 (COVID-19) Recovery Among Health Care Workers
Sponsor: Hackensack Meridian Health
Terminated
Challenges in enrollment
Other terminated trials from Hackensack Meridian Health
A PHASE1 clinical study on COVID-19, this trial is terminated or withdrawn. The trial is conducted by Hackensack Meridian Health and has accumulated 11 data snapshots since 2022. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
11 versions recorded-
Oct 2024 — Present [monthly]
Terminated PHASE1
-
Sep 2024 — Oct 2024 [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Apr 2024 — Jul 2024 [monthly]
Terminated PHASE1
Status: Completed → Terminated
-
Jan 2024 — Apr 2024 [monthly]
Completed PHASE1
▶ Show 6 earlier versions
-
Jun 2023 — Jan 2024 [monthly]
Completed PHASE1
-
May 2023 — Jun 2023 [monthly]
Completed PHASE1
Status: Recruiting → Completed
-
Jan 2023 — May 2023 [monthly]
Recruiting PHASE1
-
May 2022 — Jan 2023 [monthly]
Recruiting PHASE1
-
Mar 2022 — May 2022 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
Dec 2021 — Mar 2022 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Hackensack Meridian Health
For direct contact, visit the study record on ClinicalTrials.gov .